BPC-157Also known as: Body Protection Compound-157

Mechanism of Action

BPC-157 operates through multiple interconnected pathways that make it uniquely effective for tissue repair. Understanding these mechanisms helps explain why it has such broad applications—from healing a torn rotator cuff to resolving chronic gut inflammation.

Angiogenesis and VEGF Upregulation

The primary mechanism behind BPC-157's healing properties is its ability to promote angiogenesis—the formation of new blood vessels. BPC-157 significantly upregulates vascular endothelial growth factor (VEGF) and its receptor VEGFR2. This increased vascularization delivers more oxygen, nutrients, and growth factors to damaged tissue, dramatically accelerating the healing process.

In rat studies, BPC-157 administration increased VEGF expression by up to 3-fold in injured tissue compared to controls. This effect persists even in compromised healing environments (diabetic wounds, NSAID-impaired healing, corticosteroid use).

Growth Factor Receptor Modulation

Beyond VEGF, BPC-157 upregulates receptors for multiple growth factors critical to tissue repair:

• EGF (Epidermal Growth Factor): Promotes epithelial cell proliferation, crucial for gut lining repair
• FGF (Fibroblast Growth Factor): Stimulates fibroblast activity for collagen synthesis in tendons and ligaments
• HGF (Hepatocyte Growth Factor): Supports tissue regeneration and has anti-fibrotic effects

Nitric Oxide System Interaction

BPC-157 interacts extensively with the nitric oxide (NO) system, which explains some of its cardiovascular and gastrointestinal effects. It appears to modulate both constitutive (eNOS) and inducible (iNOS) nitric oxide synthase depending on the physiological context, promoting beneficial vasodilation while limiting excessive NO production during inflammation.

Dopaminergic System Effects

Interestingly, BPC-157 has documented effects on the dopaminergic system. It can counteract dopamine receptor supersensitivity and has shown protective effects against dopaminergic neurotoxins in animal models. This may explain anecdotal reports of improved mood and motivation during BPC-157 use, though these effects are not well-characterized in humans.

Evidence Base: What the Research Actually Shows

BPC-157 has an extensive body of animal research—hundreds of studies demonstrating efficacy for wound healing, tendon repair, gut protection, and even neurological effects. However, human clinical trials are extremely limited. This gap between animal evidence and human data is the single most important thing to understand about BPC-157.

Animal Studies (Strong Evidence)

The animal literature for BPC-157 is remarkably consistent:

• Tendon healing: Multiple rat studies show 50-80% faster tendon-to-bone healing with BPC-157 vs. placebo
• Muscle injury: Accelerated recovery from muscle crush injuries, with improved contractile function
• Ligament repair: Enhanced medial collateral ligament healing in rat models
• Gut protection: Prevented and healed NSAID-induced gastric ulcers, even with continued NSAID use
• Inflammatory bowel: Reduced colitis severity scores in multiple IBD models

Human Evidence (Limited)

As of 2026, there are only a handful of published human studies on BPC-157:

• A Phase I safety trial showing good tolerability up to 10mcg/kg
• Preliminary data on inflammatory bowel disease (results pending)
• Case reports on various musculoskeletal conditions

Protocols and Dosing

BPC-157 dosing protocols are largely derived from animal study scaling and community experience, as standardized human dosing has not been established through clinical trials.

Standard Healing Protocol

The most common protocol for tendon, ligament, or muscle injuries:

• Dose: 250-500 mcg per day
• Frequency: Once daily or split into two doses (AM/PM)
• Duration: 4-12 weeks depending on injury severity
• Administration: Subcutaneous injection near the injury site

Gut Healing Protocol

For gut-related issues (IBD, ulcers, leaky gut, NSAID damage):

• Dose: 250-500 mcg per day
• Administration: Oral (swallowed) or subcutaneous (abdominal)
• Duration: 4-8 weeks
• Timing: Empty stomach preferred for oral administration

Reconstitution

BPC-157 is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water:

• Add bacteriostatic water slowly, directing the stream against the vial wall
• Do not shake—gently swirl until dissolved
• Common reconstitution: 2mL bacteriostatic water to a 5mg vial = 2.5mg/mL (2500mcg/mL)
• Store reconstituted peptide refrigerated (2-8°C)
• Use within 4-6 weeks of reconstitution

Use our Peptide Reconstitution Calculator to calculate exact dosing volumes.

Stack Synergies

BPC-157 is rarely used in isolation. Its healing properties synergize powerfully with other compounds, particularly TB-500.

The Classic Healing Stack: BPC-157 + TB-500

This is the most well-established peptide combination for injury recovery:

• BPC-157: 250-500mcg/day (localized healing, angiogenesis)
• TB-500: 2-2.5mg twice weekly (systemic healing, cell migration)

The rationale: BPC-157 promotes local blood vessel formation and growth factor signaling, while TB-500 facilitates stem cell migration and systemic tissue repair. Together, they address healing from both local and systemic angles.

See the full protocol in our Injury Repair Stack Guide.

BPC-157 + Growth Hormone Secretagogues

Combining BPC-157 with GH-releasing peptides (CJC-1295, Ipamorelin) amplifies the healing response through elevated IGF-1 levels. This stack is popular for athletes recovering from surgery or significant injury.

BPC-157 During TRT

For men on testosterone replacement therapy, BPC-157 can be added during periods of increased physical stress or injury. There are no known negative interactions with testosterone, and the combination may support connective tissue health—an area where supraphysiological androgens can create vulnerability.

Side Effects and Safety

BPC-157 has an exceptionally favorable safety profile based on available data. Animal studies show no toxicity even at very high doses, and human trials (limited as they are) report minimal adverse events.

Reported Side Effects

• Injection site reactions: Mild redness, itching, or bruising (common with any injectable)
• Nausea: Occasionally reported, especially with oral administration
• Dizziness: Rare, possibly related to blood pressure modulation
• Headache: Uncommon, usually transient

Theoretical Concerns

Because BPC-157 promotes angiogenesis and cell growth, there are theoretical concerns about its use in individuals with active cancer or high cancer risk. If you have a history of cancer or suspicious lesions, do not use BPC-157 without physician guidance.

Quality Control Issues

The biggest real-world risk with BPC-157 is product quality. Because it is sold as a research chemical rather than a pharmaceutical, quality control varies dramatically:

• Request third-party testing (HPLC purity, mass spectrometry)
• Verify peptide identity and absence of bacterial contamination
• Purchase from vendors who provide Certificates of Analysis (CoA)

See our How to Read a Certificate of Analysis guide for verification steps.

Frequently Asked Questions

What is BPC-157 used for?

BPC-157 is primarily used for accelerating healing of tendons, ligaments, muscles, and the gastrointestinal tract. It promotes angiogenesis (new blood vessel formation) and has been studied for gut repair, including healing of ulcers and inflammatory bowel conditions.

How long does BPC-157 take to work?

Most users report noticeable improvements in tendon and joint pain within 2-4 weeks. Gut healing benefits may be observed sooner, often within 1-2 weeks. Full tissue remodeling for significant injuries typically requires 6-12 weeks of consistent use.

Is BPC-157 legal?

BPC-157 is not FDA-approved for human use in the United States. It exists in a legal gray area—it can be purchased for "research purposes" but is not approved for human consumption. It is not a controlled substance.

What is the best BPC-157 dosage?

The most common protocol is 250-500mcg per day, typically split into two doses (morning and evening) or administered once daily. For localized injuries, subcutaneous injection near the injury site is preferred.

Can BPC-157 be taken orally?

Yes, BPC-157 demonstrates oral bioavailability, particularly for gut-related conditions. However, for systemic healing of tendons and muscles, subcutaneous injection is more effective and better studied.

Does BPC-157 need to be cycled?

There is no established requirement to cycle BPC-157. Most protocols run 4-12 weeks based on healing needs, then discontinue once the injury has resolved. Some users run longer protocols for chronic conditions without apparent issues.

Can I use BPC-157 with NSAIDs?

Interestingly, yes—and this is one of BPC-157's unique properties. Animal studies show BPC-157 can heal NSAID-induced gut damage even with continued NSAID use. However, NSAIDs may impair tendon healing through other mechanisms, so weigh this carefully for musculoskeletal injuries.